Skip to main content

Day: July 30, 2024

Reed’s Schedules Second Quarter 2024 Conference Call for August 13 at 5:00 p.m. ET

NORWALK, Conn., July 30, 2024 (GLOBE NEWSWIRE) — Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Tuesday, August 13, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the three months ended June 30, 2024. The Company’s results will be reported in a press release prior to the call. Reed’s management will host the conference call, followed by a question-and-answer period. Date: Tuesday, August 13, 2024Time: 5:00 p.m. Eastern timeToll-free dial-in number: (800) 717-1738International dial-in number: (646) 307-1865Conference ID: 78880Webcast: Reed’s Q2 2024 Conference Call Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization....

Continue reading

Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET

DENVER, July 30, 2024 (GLOBE NEWSWIRE) — Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), will host a conference call on Tuesday, August 13, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the second quarter ended June 30, 2024. The Company’s results will be reported in a press release prior to the call. The Schwazze management team will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing ir@schwazze.com. Date: Tuesday, August 13, 2024Time: 5:00 p.m. Eastern timeToll-free dial-in: (844) 825-9789International dial-in: (412) 317-5180Conference ID: 10191294Webcast: SHWZ Q2 2024 Earnings Call The conference call...

Continue reading

Reliance Global Group Announces Advanced Quote & Bind InsurTech Solution for Commercial Policies Launching in Q4 2024

New offering catapults the commission earning ability of RELI Exchange agency partners LAKEWOOD, N.J., July 30, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today unveiled its new, advanced AI-powered Quote & Bind cutting-edge InsurTech solution for commercial policies, designed to significantly enhance the capabilities of RELI Exchange agency partners. The Company plans to launch the new offering in the fourth quarter of 2024. The new Quote & Bind solution, integrated within the RELI Exchange platform, leverages artificial intelligence, enabling agents to provide real-time commercial insurance quotes from multiple carriers and bind policies in real time from the RELI Exchange agent dashboard. These new commercial lines of insurance include workers’ compensation,...

Continue reading

Century Fire Protection Acquires Citadel Fire Sprinkler and Sentry Fire Protection

Tuck-Under Acquisitions Add Scale and Broaden Footprint in Existing Markets TORONTO, July 30, 2024 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that its subsidiary, Century Fire Protection (“Century”), has recently acquired Citadel Fire Sprinkler, Inc. (“Citadel”) and Sentry Fire Protection Co., Inc. (“Sentry”). The existing management teams of both businesses have retained minority equity interests and will continue to oversee their respective day-to-day operations. Terms of the two transactions were not disclosed. Citadel, founded in 2013 and headquartered in Birmingham, Alabama, provides fire sprinkler design and installation services to a broad range of commercial and industrial clients in Alabama, Tennessee and Mississippi.   Established in 2008 and based in Asheboro, North...

Continue reading

Martinrea International Inc. to Announce Second Quarter Results on August 6, 2024

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) — Martinrea International Inc. (TSX : MRE) today announced it will report its financial results for the second quarter ended June 30, 2024 on Tuesday, August 6, 2024 after the markets close, and will hold a conference call to discuss the results the same day at 5:30 p.m. Eastern Time. To participate, please dial 416-641-6104 (Toronto area) or 800-952-5114 (toll free Canada and US) and enter participant code 8636388#. Please call 10 minutes prior to the start of the conference call. The conference call will also be webcast live in listen‐only mode and archived for twelve months. The webcast and accompanying presentation can be accessed at: https://www.martinrea.com/investor-relations/events-presentations/ There will also be a rebroadcast of the call available by dialing 905-694-9451 or toll...

Continue reading

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

The U.S. addressable market for Dry Eye Disease is valued at over $3 billion by independent sources NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, and SGN Nanopharma, today announced that the companies have entered into a collaboration agreement to develop a treatment for chronic dry eye disease. Under the terms of the agreement, the companies will work to develop SGN’s Micellar Nanoparticle Platform (MNP) platform-based cyclosporine formulation for use with Eyenovia’s Optejet® dispenser. The companies are currently validating the novel drug-device combination product’s manufacturability to support clinical testing and will then schedule a consultation meeting with the FDA...

Continue reading

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2024. “In Q2, we saw continued progress against core development goals for each of the components of our platform,” said Sujal Patel, CEO of Nautilus. “We believe we are pioneering a fundamentally new approach that holds the potential to overcome the limitations of traditional and peptide-based protein analysis methods and to unlock the value of the proteome – both in targeted proteoform analysis and broadscale discovery – something we continue to view as one of the most significant untapped opportunities in biological science.” Second Quarter 2024 Financial Results Operating expenses were $20.8...

Continue reading

IPG Photonics Announces Second Quarter 2024 Financial Results

Prioritizing Investment in Innovation Pipeline While Optimizing Business for Cash Generation MARLBOROUGH, Mass., July 30, 2024 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the second quarter ended June 30, 2024.  Three Months Ended June 30,           Six Months Ended June 30,        (In millions, except per share data and percentages)   2024       2023       Change       2024       2023       Change  Revenue $ 257.6     $ 340.0       (24 )%   $ 509.7     $ 687.1       (26 )%Gross margin   37.3 %     43.4 %             38.0 %     42.9 %        Operating income $ 12.0     $ 72.1       (83 )%   $ 31.1     $ 147.5       (79 )%Operating margin   4.7 %     21.2 %             6.1 %     21.5 %        Net income attributable to IPG Photonics Corporation $ 20.2     $ 62.3       (68 )%   $ 44.3     $ 122.5       (64 )%Earnings...

Continue reading

ITW Reports Second Quarter 2024 Results

Revenue of $4.0 billion, a decrease of 1% with flat organic growth Operating income of $1.05 billion, an increase of 4.5% Operating margin of 26.2%, an increase of 140 bps as enterprise initiatives contributed 140 bps GAAP EPS of $2.54, an increase of 2%; Excl. a one-time 2023 tax item, EPS increased 5% Narrowing full year GAAP EPS guidance to a range of $10.30 to $10.40 per shareGLENVIEW, Ill., July 30, 2024 (GLOBE NEWSWIRE) — Illinois Tool Works Inc. (NYSE: ITW) today reported its second quarter 2024 results and updated guidance for full-year 2024. “While the demand environment continued to moderate across our portfolio, we delivered a solid quarter with strong operational execution and profitability,” said Christopher A. O’Herlihy, President and Chief Executive Officer. “Our ability to overcome near-term macro challenges...

Continue reading

Amplify ETFs Declares July Income Distributions for its ETFs

CHICAGO, July 30, 2024 (GLOBE NEWSWIRE) — Amplify ETFs announces July income distributions for its ETFs.ETF Name Ticker Amount per Share Ex-Date Record Date Payable DateAmplify High Income ETF YYY $0.12000 7/30/2024 7/30/2024 7/31/2024Amplify CWP Enhanced Dividend Income ETF DIVO $0.15843 7/30/2024 7/30/2024 7/31/2024Amplify Natural Resources Dividend Income ETF NDIV $0.13369 7/30/2024 7/30/2024 7/31/2024Amplify CWP International Enhanced Dividend Income ETF IDVO $0.15360 7/30/2024 7/30/2024 7/31/2024Amplify Cash Flow Dividend Leaders ETF COWS $0.03647 7/30/2024 7/30/2024 7/31/2024Amplify Cash Flow High Income ETF HCOW $0.17513 7/30/2024 7/30/2024 7/31/2024Amplify Samsung SOFR ETF SOF $0.44767 7/30/2024 7/30/2024 7/31/2024About Amplify ETFsAmplify ETFs, sponsored by Amplify Investments, has over $9 billion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.